Category: Partners

  • Askeladden Capital Announces AstroNova “Town Hall” Forum

    Askeladden Capital Announces AstroNova “Town Hall” Forum

    All AstroNova Stakeholders Invited to Meet and Interact with Askeladden’s Board Candidates

    Askeladden Nominees Have Specific and Relevant Expertise to Execute Askeladden’s Plan to Maximize Value

    Transdigm’s Recently Raised Bid for Aerospace Components Company Servotronics Highlights Potential to Unlock Value at AstroNova with Better Governance

    FORT WORTH, TX / ACCESS Newswire / June 2, 2025 / Dear AstroNova stakeholders:

    I write to you as the founder and portfolio manager of Askeladden Capital (collectively, “we,”) which is AstroNova’s largest shareholder, owning approximately 9.2% of the company on behalf of our clients.

    In an effort to improve AstroNova’s performance for the benefit of shareholders, employees, and all other stakeholders, we have nominated five highly qualified individuals for election to AstroNova’s Board of Directors at the company’s Annual Meeting, scheduled for July 9, 2025.

    We invite you to join an Investor Forum where shareholders, employees, and all other interested parties can interact directly with our nominees. After a brief introduction and panel discussion of approximately 20 minutes, we will open up the call for Q&A.

    We will conduct this “town hall” style meeting virtually via Zoom at 11:00 AM Eastern Time (10:00 AM Central Time) on Thursday, June 12, 2025. You can register here :

    https://zoom.us/webinar/register/WN_P4nfq0iOSamSBEiaDZ0IZA#/registration

    Please contact Samir Patel via samir@askeladdencapital.com if you have any trouble registering.

    Attendees will have the option to remain anonymous to all parties other than the host. Those who cannot attend live are also invited to email us with written questions that we will read and answer during the town hall as time permits. A recording of the call will subsequently be made available.

    We encourage candid and detailed questions – the more challenging the better – about our research, our plan, our nominees’ backgrounds, and how we will work as a team to maximize the value of AstroNova for all. Please ask similar questions of the incumbents, then vote based on whose answers you find more compelling.

    Askeladden has researched AstroNova since 2016 and been a 5% shareholder since 2020. Since March, we have spoken to over 15 individuals, ranging from former employees to suppliers and other industry veterans, to deepen our understanding of the company. In the near future, we will share selected research findings with AstroNova shareholders.

    We believe AstroNova has many strengths, such as a large installed base and many talented employees. Unfortunately, we believe that these attractive qualities have been overwhelmed by poor governance and management by the incumbent Board, and CEO Greg Woods, which has harmed shareholders and employees alike. In FY2025, the company reported Adjusted EBITDA of $12.3 million, substantially below FY2024’s $17.6 million and FY2025 original guidance of ~$21 million at the midpoint. [1]

    The company’s May 2024 acquisition of MTEX should have further enhanced profitability – instead, the CEO and Board’s decision to spend $18.7 million in cash and assume additional debt [2] to fund this acquisition harmed both shareholders and employees. The share price fell almost 50% over the ensuing year, [3] while employees have faced layoffs. [4]

    In FY2025, MTEX generated an operating loss of $16.9 million, including a goodwill impairment of $13.4 million, and the company subsequently discontinued 70% of MTEX’s product portfolio. [5] [6]

    As a result of the lower earnings and increased debt due to the MTEX acquisition, the company breached its debt covenants and suffered an event of default under its credit facility during the quarter ended January 31, 2025 (thus forcing AstroNova to seek a waiver from its lender, which was subsequently granted). [7]

    While CEO Greg Woods retains his job despite this self-inflicted debacle, many AstroNova employees were not so lucky: on March 20, 2025, the company announced “the reduction of approximately 10% of the Company’s global workforce, primarily in the PI [Product Identification] segment.” [8] Through no fault of their own, rather than enjoying the profit-sharing and career growth opportunities that a well-managed company should provide, 10% of AstroNova employees lost their jobs.

    Despite these missteps, incumbents appear to be doubling down on this failed strategy, and have refused to engage with Askeladden’s efforts to improve the company’s performance.

    We recently published a 20-page document including our specific, research-based plan for improving AstroNova’s performance, as well as relevant background information on the company’s performance and governance. We believe that our nominees have specific and relevant qualifications to address the current challenges faced by AstroNova. Below is their biographical information.

    Shawn Kravetz. Mr. Kravetz has relevant experience as a change agent under similar circumstances. He joined the Board of Nevada Gold & Casinos, Inc. as a large shareholder frustrated by performance, including a recent acquisition. He served from 2016 until Nevada Gold was sold in 2019, including Chairman of the Corporate Governance and Nominating Committee. Mr. Kravetz was recently nominated for election to the Board of publicly traded Spruce Power Holding Corporation by the company’s Nominating and Governance Committee. [9]

    Jeff Sands. As Mr. Sands discusses in his book, “Corporate Turnaround Artistry: Fix Any Business in 100 Days,” he has successfully used techniques included in our plan to restore profitability at numerous businesses, including some merely weeks away from lender-forced liquidation. He has won the Turnaround Management Association “Turnaround of the Year” award three times. Mr. Sands has successfully worked with businesses such as a $100M supplier of aerospace components to Boeing (~2x the size of AstroNova’s Aerospace segment), as well as complex and capital-intensive businesses such as steel and pharmaceuticals. Given AstroNova’s significant recent decline in profitability and elevated inventory balances, Mr. Sands’ experience in driving rapid cash flow improvement is extremely relevant. Mr. Sands has been involved in the sale of numerous private companies.

    Ryan Oviatt. Mr. Oviatt has extensive experience – as CFO, CEO, and Board Member of Profire – of managing an industrial products business for margin and cash flow in the highly cyclical energy market. Mr. Oviatt managed a team that used techniques such as automation of manual processes and key administrative functions, customer outreach, and performance-based incentive compensation programs designed to instill a sense of ownership throughout the company. Mr. Oviatt helped lead the successful sale of Profire to a strategic public-company buyer, CECO Environmental. After multiple rounds of negotiation, Profire successfully achieved a final offer price 27.5% higher than CECO’s original offer, and an all-cash deal rather than the original offer of 75% cash and 25% stock. This final offer represented a 60.3% premium to Profire’s volume-weighted average share price over the 30 days prior to the Board approving the merger. [10]

    Boyd Roberts. Mr. Roberts was the youngest member of the executive team at Franklin Covey (FC) and has integrated and substantially grown an acquired division, with ownership of full P&Ls and high employee net promoter scores. Mr. Roberts has extensive experience with Franklin Covey’s customer-focused recurring-revenue business model. Mr. Roberts is fluent in Portuguese. His linguistic and cultural strengths uniquely qualify him to address the challenging MTEX acquisition, which we believe has suffered due to a cultural mismatch between the labor force at its facility in Porto in northern Portugal, and AstroNova’s American business culture. [11]

    Samir Patel. As AstroNova’s largest shareholder, who has researched the business since 2016, I am deeply familiar with the company’s ongoing (flawed) strategy, contrary to the company’s misleading assertion that the company will be damaged by a new Board “unacquainted with recent decision-making .” [12] I will ensure that AstroNova’s operational and capital allocation decisions consistently maximize shareholder value.

    As a point of comparison on what AstroNova could potentially be worth with better governance, we note that Servotronics (SVT), a global designer and manufacturer of servo controls and other components for aerospace and defense applications, announced a merger with large aerospace manufacturer Transdigm (TDG) for $110 million in cash on May 19, 2025, and subsequently raised the offer price by ~22% from $38.50 to $47.00 after Servotronics received another offer from a competing bidder, suggesting significant interest in the business at that valuation. [13] Even the original offer price – let alone the subsequent increase – is almost identical to AstroNova’s entire enterprise value as of May 20, 2025. [14] [15]At the original offer price, the all-cash transaction represented a 274% premium to Servotronics’ share price at the prior close. For the fiscal year 2024, Servotronics generated $44.9 million in revenue with only $8.2 million in gross profit and less than $1 million in Adjusted EBITDA. [16]

    Meanwhile, for its FY2025 which ended a month later, AstroNova’s Test and Measurement segment (subsequently renamed Aerospace) generated a slightly higher $48.9 million in revenues with a much higher $11.1 million in segment operating profit. It seems reasonable to assume that a buyer evaluating these two businesses side by side would assign a higher valuation to AstroNova Aerospace given its modestly higher revenues and substantially higher profits. In other words (and apart from any tax considerations), that would imply that if AstroNova Aerospace was sold at a similar value to Servotronics’ original agreement – let alone the higher subsequent agreement raising the offer amount by over 20% – AstroNova could pay off all its debt and return cash to shareholders equivalent to roughly the current share price. Shareholders would then still own the entire Product Identification segment, with slightly over $100 million in annual revenues generated each of the past three fiscal years, which is clearly worth substantially more than the zero or even negative value implied if Servotronics’ valuation is applied to AstroNova Aerospace. [17]

    While the Servotronics transaction is merely one data point, it demonstrates the potential value if AstroNova implements the strategy we have developed – which we recently presented in our public plan – rather than doubling down on a strategy promoted by the value-destroying incumbent CEO and Board. In the more than eleven years from February 1, 2014 (when Mr. Woods became CEO) through May 15, 2025 (the record date of this year’s Annual Meeting), AstroNova shares have experienced a total return of negative 28%. [18]

    You can find further information about the upcoming board election, scheduled for July 9, 2025, at the AstroNova page on the Askeladden Capital website : https://www.askeladdencapital.com/astronova/

    These documents will also be available at no cost at www.sec.gov .

    As stated previously, the “town hall” will occur virtually via Zoom at 11:00 AM Eastern Time (10:00 AM Central Time) on Thursday, June 12, 2025. You can register here :

    https://zoom.us/webinar/register/WN_P4nfq0iOSamSBEiaDZ0IZA#/registration

    Please feel free to reach out to me with any questions or comments, at samir@askeladdencapital.com or (682) 553-8302. We look forward to earning your vote.

    Cordially,

    Samir Patel

    Founder and Portfolio Manager, Askeladden Capital

    Samir Patel, Askeladden Capital Management LLC, Jeff Sands, Shawn Kravetz, Ryan Oviatt and Boyd Roberts (collectively the “Participants”) filed a definitive proxy statement and accompanying proxy card with the SEC on May 20, 2025, as amended on May 21, 2025, to be used in soliciting proxies in connection with the 2025 annual meeting of shareholders (the “Annual Meeting”) of AstroNova, Inc. (the “Company”). All shareholders of the Company are advised to read the Proxy Statement and other documents related to the solicitation of proxies, each in connection with the Annual Meeting, by the Participants, as they contain important information, including additional information related to the Participants, including a description of their direct or indirect interests by security holdings or otherwise. The Proxy Statement and an accompanying GOLD proxy card will be furnished to some or all of the Company’s stockholders and is, along with other relevant documents, available at no charge on the SEC website at http://www.sec.gov, or by contacting Samir Patel at 1452 Hughes Road, Suite 200 #582, Grapevine, TX, 76051.


    [1] Q4 FY2024 and Q4 FY2025 Earnings Release.

    [2] FY2025 Form 10-K filed April 15, 2025.

    [3] Stock price data from YCharts.

    [4] FY2025 Form 10-K, page 24.

    [5] AstroNova Form 10-K for FY2025. Impairment discussed on page 11; purchase price discussed on page 15.

    [6] MTEX Acquisition Announcement and Conference Call Transcript (May 9, 2024) and FY2025 Form 10-K filed April 15, 2025.

    [7] Form 8-K Earnings filed March 21, 2025.

    [8] FY2025 Form 10-K, page 24.

    [9] Spruce Power Holding Corp Definitive Proxy, page 10.

    [10] Profire Energy (PFIE) SC14D9 dated December 3, 2024. Section “Background of the Offer and the Merger” on pages 9 – 16. https://www.sec.gov/Archives/edgar/data/1289636/000110465924124898/tm2429518-1_sc14d9.htm

    [11] “The American work culture focuses on ambition… in Portugal, there is a more collective approach to work and less pressure… [people] tend to place greater importance on personal well-being, family time, and life outside of work.” LXUS (Corporate Relocation service provider.) https://www.lxusportugal.com/blog-lxusportugal/cultural-comparison-between-the-usa-and-portugal

    [12] Letter accompanying AstroNova’s definitive proxy statement, filed May 19, 2025.

    [13] “TransDigm raises offer price for Servotronics to $47/share.” Seeking Alpha. May 29, 2025. https://seekingalpha.com/news/4453416-transdigm-raises-offer-price-for-servotronics-to-47-share

    [14] “Transdigm to Acquire Servotronics For About $110 million.” Nasdaq. May 19, 2025. https://www.nasdaq.com/articles/transdigm-acquire-servotronics-about-110-mln

    [15] Per data sources such as Seeking Alpha, ALOT shares closed at $9.12 on May 20, 2025. The company’s recent definitive proxy statement, filed May 19, 2025, discloses a recent sharecount of approximately 7.6 million shares, for a market cap of approximately $69 million as of that date. AstroNova’s Form 10-K filed April 15, 2025 discloses $20.9 million outstanding on the revolving credit facility, $6.1 million in current long-term debt, $0.6 million in short-term debt, and $19 million in long-term debt, for a total of $46.6 million in gross debt. The same Form 10-K disclosed $5 million of cash and equivalents, making net debt $41.6 million. The sum of $41 million and $69 million is approximately $110 million.

    [16] Form 10-K for Servotronics SVT filed March 17, 2025.

    [17] AstroNova Form 10-K for FY2025, filed April 15, 2025. Page 24.

    [18] Data from YChart

    Samir Patel
    samir@askeladdencapital.com
    (682) 553-8302

    SOURCE: Askeladden Capital Management LLC

    View the original press release on ACCESS Newswire

  • Newsmax to Join Russell 2000 and Russell 3000 Indexes

    Newsmax to Join Russell 2000 and Russell 3000 Indexes

    BOCA RATON, FL / ACCESS Newswire / June 2, 2025 / Newsmax Inc. (NYSE:NMAX) (“Newsmax” or the “Company”) today announced that the Company expects to list on the U.S. small-cap Russell 2000® Index, effective after the U.S. market opens on June 30, 2025, as part of the 2025 Russell indexes reconstitution.

    Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

    “The past year has been transformational for Newsmax, and we are pleased to see our shares will soon be added to the Russell 2000® Index, one of the market’s leading performance benchmarks in North America,” said Chris Ruddy, CEO of Newsmax.

    Newsmax, a television and digital media company offering Americans independent news, went public on the NYSE in March.

    Since then, Newsmax has made several major announcements, including expanded cable / pay TV distribution on Hulu+, putting Newsmax into top-tier penetration of around 60 million U.S. homes.

    “We feel this addition of Newsmax on the Russell Index will help raise awareness and ownership of Newsmax within the institutional investment community,” continued Ruddy.

    Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $10.6 trillion in assets are benchmarked against Russell’s U.S. indexes. Russell indexes are also part of FTSE Russell, a leading global index provider.

    About Newsmax

    Newsmax Media, Inc. operates Newsmax, the nation’s fourth highest-rated cable news network, according to Nielsen. Newsmax is carried on all major cable, satellite systems, and virtual pay TV operators. Newsmax reaches more than 40 million Americans regularly through Newsmax TV, the Newsmax+ App, its popular website Newsmax.com, and publications like Newsmax Magazine. Reuters Institute says Newsmax is one of the top 12 U.S. news brands and Forbes has called us “a news powerhouse.”

    For more information, please visit Investor Relations | Newsmax Media, Inc.

    About FTSE Russell, an LSEG Business

    FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives. A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering.

    FTSE Russell is wholly owned by London Stock Exchange Group.

    For more information, visit FTSE Russell.

    Forward-Looking Statements

    This communication contains forward-looking statements. From time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Forward-looking statements can be identified by those that are not historical in nature. The forward-looking statements discussed in this communication and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. Newsmax does not guarantee future results, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. Forward-looking statements should not be relied upon as predictions of future events. We are under no duty to update any of these forward-looking statements after the date of this communication to conform our prior statements to actual results or revised expectations, and we do not intend to do so. Factors that may cause actual results to differ materially from current expectations include various factors, including but not limited to any changes in indications we have received from FTSE Russell regarding inclusion in certain indexes, our ability to change the direction of Newsmax, our ability to keep pace with new technology and changing market needs, the competitive environment of our business changes in domestic and global general economic and macro-economic conditions and/or uncertainties and factors set forth in the sections entitled “Risk Factors” in Newsmax’s Annual Report on Form 10-K for the twelve months ended December 31, 2024, Newsmax’s Quarterly Report on Form 10-Q for the three months ended March 31, 2025, and other filings Newsmax makes with the Securities and Exchange Commission. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. Undue reliance should not be placed on forward-looking statements in this communication, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein.

    Investor Contacts

    Newsmax Investor Relations
    ir@newsmax.com

    SOURCE: Newsmax Inc.

    View the original press release on ACCESS Newswire

  • New Geological Data Confirms Potential for Expanded Gold and REE Deposits at Colosseum Project

    New Geological Data Confirms Potential for Expanded Gold and REE Deposits at Colosseum Project

    SYDNEY, AUSTRALIA / ACCESS Newswire / June 2, 2025 / Dateline Resources Limited (ASX:DTR)(OTC:DTREF) announces an update on its 100%-owned Colosseum Gold and Rare Earth Element (REE) Project in California, detailing recent exploration findings and planned activities for 2025. Recent geological mapping and data analysis indicate the potential for the project’s known resources to be significantly larger, based on evidence of a potentially broader mineralized system.

    The Colosseum Project has a JORC-2012 compliant Mineral Resource of 27.1 million tons at 1.26 g/t gold, totaling 1.1 million ounces, with 455,000 ounces classified as Measured, 281,000 ounces as Indicated, and 364,000 ounces as Inferred. An economic assessment announced on May 23, 2025, reported an NPV of US$550 million and an IRR of 61% at a gold price of US$2,900/oz.

    Recent re-examination of 2023 gravity survey data, cross referenced with new geochemical results, shows that gravity low anomalies align with the historically mined North and South breccia pipes and newly identified felsite outcrops located 200-900 meters west and southwest of the previously mined pits. This correlation suggests the presence of additional breccia pipes, which could host further gold mineralization. The data supports an interpretation of the Colosseum deposit as a larger breccia pipe complex, with the mined pipes potentially representing only the upper, eroded portions of a more extensive system.

    Figure 1: Cross-section A-A′ (looking approximately north) showing the drilled Colosseum breccia pipe (blue volume) cantered within a pronounced gravity low (light blue colour) and recently sampled felsite dykes (red arrows) to the west also sit in gravity lows.

    To further define this potential, Dateline will commence a comprehensive exploration program in June 2025. A four-week soil geochemical survey will collect samples across the project area on systematic grids to identify gold, REE, and pathfinder element anomalies. Concurrently, a magneto telluric (MT) geophysical survey will begin in late June to map subsurface structures and potential REE-bearing carbonatite bodies. These surveys will provide complementary datasets to refine drill targets. Dateline’s technical team will integrate gravity, geochemical, and MT data to prioritize areas where these indicators converge, enhancing the likelihood of identifying potential mineralized zones.

    Figure 2: Plan view map showing gravity data overlaid with proposed soil sampling locations (purple dots at 60 m spacing). The mined North and South breccia pipes lie within a central gravity low (blue), while newly sampled felsite outcrops on the western margin also coincide with a gravity low. Two circular gravity lows to the east of the pits represent untested potential breccia pipe targets. The soil sampling program is designed to geochemically test all these features to support vectoring for both gold and REE mineralisation

    A dedicated REE drilling program is being finalized to test high-priority targets, including depth extensions of REE-bearing fenite/trachyte dykes and coincident gravity-MT anomalies. Drilling will also probe for extensions of the known gold-bearing breccia pipes and newly indicated targets. The program, supported by REE geologists Dr. Tony Mariano and Tony Mariano Jr., aims to confirm the presence and scale of additional gold and REE mineralization.

    The Colosseum Project is located in the Walker Lane Trend, less than 10km from the Mountain Rare Earth mine, positioning it favorably for REE exploration. The combination of existing resources, new geological insights, and planned exploration supports the potential for significant resource growth.

    About Dateline Resources Limited

    Dateline Resources Limited (ASX:DTR) is an Australian publicly listed company focused on high-value mining and exploration in North America. The Colosseum REE and Gold Project, located in California’s Walker Lane Trend, is a flagship asset with emerging REE potential and proven gold resources.

    Forward-Looking Statements

    This press release contains “forward-looking statements” within the meaning of applicable securities laws. These statements relate to future events or future performance and include, but are not limited to, statements regarding the potential of the Colosseum Project, the expected benefits of the OTCQB listing, the company’s plans for future development, and the strategic importance of the project for U.S. critical minerals supply. Forward-looking statements are based on the company’s current expectations, estimates, and projections, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to: fluctuations in the prices of gold and rare earth elements; changes in regulatory requirements or permitting processes; geological or technical challenges in exploration and development; market conditions affecting the company’s ability to raise capital; environmental or social factors impacting operations; risks associated with the OTCQB listing process or trading on a new market; environmental and permitting risks associated with operating in a national preserve; uncertainty regarding the delineation of a mineable rare earth elements resource; risks related to the company’s ability to secure necessary funding for project development; and potential changes in government policies or priorities affecting the critical minerals sector. The company cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company does not undertake any obligation to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

    Competent Person Statement

    The exploration data has been reviewed by Mr. Greg Hall, a Chartered Professional of the Australasian Institute of Mining and Metallurgy (CP-IMM) and Non-Executive Director of Dateline. Mr. Hall, with extensive experience in IRGS-style mineralization, qualifies as a Competent Person under the JORC Code and consents to the inclusion of this information.

    Contact Information

    For further details, please contact:

    Follow Dateline on X: @Dateline_DTR

    This announcement is authorized for release by the Dateline Resources Limited Board of Directors.

    SOURCE: Dateline Resources Limited

    View the original press release on ACCESS Newswire

  • Clear Start Tax Highlights How Ignoring Back Taxes Can Destroy Your Credit and Your Future

    Clear Start Tax Highlights How Ignoring Back Taxes Can Destroy Your Credit and Your Future

    IRS Debt Doesn’t Just Lead to Penalties – It Can Derail Major Life Goals, Warns Clear Start Tax

    IRVINE, CA / ACCESS Newswire / June 2, 2025 / For many Americans, back taxes may seem like a personal issue, but the consequences extend far beyond IRS notices. According to Clear Start Tax, a nationally recognized tax resolution firm, unpaid tax debt can severely damage your credit, block financial opportunities, and create lasting setbacks that impact everything from buying a home to securing a loan or job.

    “People think of the IRS as separate from their financial reputation,” said the Head of Client Solutions at Clear Start Tax. “But a tax lien or collection activity can hit your credit and your long-term goals harder than you expect.”

    What Ignoring Back Taxes Could Really Cost You

    Failing to address back taxes doesn’t just leave you with a growing balance – it opens the door to enforcement actions that can affect your income, assets, and long-term financial health. As Clear Start Tax explains, IRS collection efforts often begin quietly but can escalate quickly and aggressively if left unresolved. Some of the most serious consequences include:

    • Tax liens can be filed against your property and reported to credit bureaus, reducing credit scores and limiting your ability to borrow.

    • Bank levies can drain your accounts with little warning, leaving you without access to needed funds.

    • Wage garnishments can reduce your take-home pay and create a cycle of financial instability.

    • Interest and penalties compound daily, quickly increasing what you owe.

    Clear Start Tax notes that these consequences don’t just harm your current finances – they also delay or destroy future plans, including mortgage approvals, car loans, small business funding, and even job applications with financial background checks.

    Credit Damage Can Linger Long After the Tax Is Paid

    Even after a tax debt is resolved, the financial damage can linger. Public records like tax liens (when reported) and collection actions can remain on credit reports for years. And if a taxpayer entered into a payment plan late-or only after enforcement began-that history may still reflect negatively in the eyes of lenders or employers.

    “Back taxes aren’t just a balance to pay-they can become a barrier to progress,” added the Head of Client Solutions at Clear Start Tax. “We’ve worked with clients who couldn’t refinance their homes or qualify for financing because of unresolved tax issues that were years old.”

    How Clear Start Tax Helps Clients Protect Their Credit and Rebuild Confidence

    Clear Start Tax offers personalized solutions that do more than just address the debt-they help safeguard credit and prevent long-term damage. The firm works with each client to:

    • Conduct a full IRS and credit risk review

    • Recommend the right IRS program (such as Offer in Compromise, Installment Agreement, or CNC status)

    • Prevent or remove liens and stop garnishments

    • Ensure timely filings to maintain eligibility for relief

    • Provide guidance on staying compliant to rebuild financial health

    With the right strategy and early action, most taxpayers can avoid the worst outcomes and take back control of their financial future.

    About Clear Start Tax

    Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm’s unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry.

    Need Help With Back Taxes?

    Click the link below:
    https://clearstarttax.com/qualifytoday/

    Contact Information

    Clear Start Tax
    Corporate Communications Department
    seo@clearstarttax.com
    (949) 535-1627

    SOURCE: Clear Start Tax

    View the original press release on ACCESS Newswire

  • Arrive AI Appoints Former FedEx Executive Laurie Tucker to Board of Directors

    Arrive AI Appoints Former FedEx Executive Laurie Tucker to Board of Directors

    INDIANAPOLIS, INDIANA / ACCESS Newswire / June 2, 2025 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network anchored by patented AI-powered Arrive Points™, announced today that Laurie Tucker, has joined its Board of Directors. Tucker, a former Senior Vice President of Marketing at FedEx and an experienced board member, brings invaluable logistics and strategic expertise to Arrive AI.

    “Laurie Tucker’s proven ability to innovate in last-mile logistics is a tremendous asset for Arrive AI,” said Dan O’Toole, CEO of Arrive AI. “We look forward to her inputs to our strategic vision to accelerate our enabling of autonomous last-mile delivery with our AI-powered Arrive Points, delivering unmatched efficiency and security for customers and value for shareholders.”

    Tucker’s impressive career includes nearly 14 years with FedEx services, culminating in executive management roles. Tucker currently chairs the Memphis, Tenn., Women’s Advocacy Center board and has served on numerous boards, including zignyl llc, Forward Air Corporation, Bread Financial, Iron Mountain and the University of Memphis Board of Visitors. She is also the co-founder and chief strategy officer of Calade Partners and is the former executive director of the Economic Club of Memphis.

    “Joining Arrive AI at this pivotal moment is incredibly exciting,” said Laurie Tucker. “Their leadership in enabling autonomous last-mile delivery through the innovative Arrive Points system is transforming logistics. I’m eager to contribute to Arrive AI’s growth and help solidify its position as the industry frontrunner.”

    Tucker’s board experience at Iron Mountain and Bread Financial Holdings, coupled with her role as Chairman of the Nominating/Governance Committee at Forward Air, underscores her ability to navigate complex markets. She will serve as Head of Arrive AI’s Compensation Committee, effective immediately.

    Arrive AI makes autonomous delivery work, ensuring security and chain-of-custody to the intended recipients at the right time. The company provides tracking data, smart logistics alerts and advanced custody controls to secure last-mile delivery for shippers, delivery services, and autonomous networks. Arrive AI’s foundational patent – for a universal access point that asynchronously interacts with people, robots and drones – was filed four days before Amazon’s. Since then, the company has expanded its IP portfolio to include numerous claims and patents such as climate assistance and anti-theft features.

    -30- 

    About Arrive AI

    Arrive AI’s patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox, whether by drone, ground robot or human courier. The platform provides real-time tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting and security systems to streamline the entire last-mile delivery experience. Learn more at www.arriveai.com.

    Media contact: Cheryl Reed at media@arriveai.com

    Investor Relations Contact: Alliance Advisors IR, ARAI.IR@allianceadvisors.com

    Cautionary Note Regarding Forward Looking Statements 

    This news release and statements of Arrive AI’s management in connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “potential”, “will”, “should”, “could”, “would” ,”optimistic” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI’s Registration Statement for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

    SOURCE: Arrive AI Inc.

    View the original press release on ACCESS Newswire

  • CoTec Holdings Corp. Announces TSXV Approval Of Convertible Loan With Kings Chapel International Limited

    CoTec Holdings Corp. Announces TSXV Approval Of Convertible Loan With Kings Chapel International Limited

    VANCOUVER, BC / ACCESS Newswire / June 2, 2025 / CoTec Holdings Corp. (TSXV:CTH) (“CoTec” or the “Company“) today announces that it has received the approval of the TSX Venture Exchange (the “TSXV“) for the conversion component of its convertible loan agreement dated November 25, 2024 (as amended, the “Convertible Loan Agreement“) with Kings Chapel International Limited (“Kings Chapel“), previously disclosed in the Company’s news releases dated November 25, 2024 and February 28, 2025.

    The outstanding principal amount under the Convertible Loan Agreement as at May 30, 2025 is $6,351,387 and $664,668 in interest has accrued thereunder.

    The outstanding principal amount under the Convertible Loan Agreement will be converted into common shares of the Company (“Common Shares“) (i) at any time at Kings Chapel’s election, at a price of CAD$0.75 per Common Share, and (ii) automatically at a price of CAD$0.75 per Common Share, on the first day on which the volume weighted average trading price of the Common Shares on the principal stock exchange on which the Common Shares are then traded over the immediately preceding 15 trading days is equal to or greater than CAD$1.00. No conversion of the outstanding principal amount will occur to the extent that, after giving effect to the conversion, Kings Chapel, its affiliates and any person with whom Kings Chapel or its affiliates would own more than 49% of the outstanding Common Shares.

    Kings Chapel is an existing insider and Control Person (as defined by TSX Venture Exchange (“TSXV“) Rules) of the Company. Julian Treger, a director of the Company and its Chief Executive Officer, is a beneficiary of a family trust associated with Kings Chapel. As a result, the execution of the Convertible Loan Agreement was a related party transaction subject to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI61-101“). The execution of the Convertible Loan Agreement was exempt from the formal valuation requirements of MI 61-101 pursuant to subsection 5.5(b) of MI 61-101 because the Common Shares are listed only on the TSXV and is exempt from the minority shareholder approval requirements of MI 61-101 pursuant to subsection 5.7(1)(a) of MI 61-101 because the fair market value of neither the Convertible Loan Agreement nor the Common Shares issuable pursuant to the conversion of the outstanding principal amount under the Convertible Loan Agreement exceed 25% of the Company’s market capitalization as determined in accordance with MI 61-101.

    All securities issuable in connection with the Convertible Loan Agreement will be subject to a statutory hold period of four months plus a day from the date of the Convertible Loan Agreement in accordance with applicable securities legislation in Canada.

    About CoTec

    CoTec is a publicly traded investment issuer listed on the TSXV and the OTCQB and trades under the symbol CTH and CTHCF respectively. CoTec is a forward-thinking resource extraction company committed to revolutionizing the global metals and minerals industry through innovative, environmentally sustainable technologies and strategic asset acquisitions. With a mission to drive the sector toward a low-carbon future, CoTec employs a dual approach: investing in disruptive mineral extraction technologies that enhance efficiency and sustainability while applying these technologies to undervalued mining assets to unlock their full potential. By focusing on recycling, waste mining and scalable solutions, the Company accelerates the production of critical minerals, shortens development timelines, and reduces environmental impact. CoTec’s strategic model delivers low capital requirements, rapid revenue generation and high barriers to entry, positioning it as a leading mid-tier disruptor in the commodities sector.

    For more information, please visit www.cotec.ca.

    For further information, please contact:

    Braam Jonker – (604) 992-5600

    Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

    SOURCE: CoTec Holdings Corp.

    View the original press release on ACCESS Newswire

  • 5E Advanced Materials to Participate in the MicroCap Rodeo Conference on June 4, 2025

    5E Advanced Materials to Participate in the MicroCap Rodeo Conference on June 4, 2025

    HESPERIA, CA / ACCESS Newswire / June 2, 2025 / 5E Advanced Materials, Inc.(NASDAQ:FEAM)(ASX:5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas Complex, announced today that Chief Executive Officer Paul Weibel will present at the MicroCap Rodeo Conference on Wednesday, June 4, 2025, in New York City. In addition to the live presentation, management will host one-on-one meetings with investors registered to attend the event.

    The presentation will begin at 2:30 p.m. ET on June 4. Investors interested in viewing the webcast can register here. The webcast and associated presentation can also be accessed through the investor section of the Company’s website at: https://investors.5eadvancedmaterials.com/events-presentations.

    For more details about the MicroCap Rodeo Conference in New York City, please visit https://www.microcaprodeo.com/.

    About 5E Advanced Materials, Inc.

    5E Advanced Materials, Inc. (NASDAQ:FEAM)(ASX:5EA) is focused on becoming a vertically integrated global leader and supplier of boron specialty and advanced materials, complemented by lithium co-product production. The Company’s mission is to become a supplier of these critical materials to industries addressing global decarbonization, food and domestic security. Boron and lithium products will target applications in the fields of electric transportation, clean energy infrastructure, such as solar and wind power, fertilizers, and domestic security. The business strategy and objectives are to develop capabilities ranging from upstream extraction and product sales of boric acid, lithium carbonate and potentially other co-products, to downstream boron advanced material processing and development. The business is based on our large domestic boron and lithium resource, which is located in Southern California and designated as Critical Infrastructure by the Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency.

    Forward-Looking Statements

    This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements other than statements of historical fact included in this press release regarding the Company’s business strategy, plans, goals, and objectives, including regarding the anticipated changes to the Company’s board of directors and management and anticipated benefits, are forward-looking statements. When used in this press release, the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “budget,” “target,” “aim,” “strategy,” “plan,” “guidance,” “outlook,” “intent,” “may,” “should,” “could,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on the Company’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. We caution you that these forward-looking statements are subject to all of the risks and uncertainties, most of which are difficult to predict and many of which are beyond our control, incident to the extraction of the critical materials we intend to produce and advanced materials production and development. These risks include, but are not limited to: our limited operating history in the borates and lithium industries and no revenue from our proposed extraction operations at our properties; our need for substantial additional financing to execute our business plan and our ability to access capital and the financial markets; our status as an exploration stage company dependent on a single project with no known Regulation S-K 1300 mineral reserves and the inherent uncertainty in estimates of mineral resources; our lack of history in mineral production and the significant risks associated with achieving our business strategies, including our downstream processing ambitions; our incurrence of significant net operating losses to date and plans to incur continued losses for the foreseeable future; risks and uncertainties relating to the development of the Fort Cady project, including our ability to timely and successfully complete our proposed Commercial Scale Boron Facility; our ability to obtain, maintain and renew required governmental permits for our development activities, including satisfying all mandated conditions to any such permits; the implementation of and expected benefits from certain reduced spending measures, and other risks and uncertainties set forth in our filings with the U.S. Securities and Exchange Commission from time to time. Should one or more of these risks or uncertainties occur, or should underlying assumptions prove incorrect, our actual results and plans could differ materially from those expressed in any forward-looking statements. These risks are not exhaustive and the information in this press release may be subject to additional risks. No representation or warranty (express or implied) is made as to, and no reliance should be place on, any information, including projections, estimates, targets, and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions, or misstatements contained herein. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as to the date of this press release.

    For additional information regarding these various factors, you should carefully review the risk factors and other disclosures in the Company’s Form 10-K filed on September 9, 2024 and subsequent filings with the U.S. Securities and Exchange Commission throughout the year, as well as in its filings under the Australian Securities Exchange. Any forward-looking statements are given only as of the date hereof. Except as required by law, 5E expressly disclaims any obligation to update or revise any such forward-looking statements. Additionally, 5E undertakes no obligation to comment on third party analyses or statements regarding 5E’s actual or expected financial or operating results or its securities.

    For further information contact:

    Joseph Caminiti or Nathan Skown
    Alpha IR Group
    FEAM@alpha-ir.com
    Ph: +1(312) 445-2870

    SOURCE: 5E Advanced Materials, Inc.

    View the original press release on ACCESS Newswire

  • Cerrado Gold Appoints Ed Guimaraes as Executive Vice President

    Cerrado Gold Appoints Ed Guimaraes as Executive Vice President

    TORONTO, ON / ACCESS Newswire / June 2, 2025 / Cerrado Gold Inc. (TSXV:CERT)(OTCQX:CRDOF)(FRA:BAI0) (“Cerrado” or the “Company“) is pleased to announce the appointment of Ed Guimaraes to the position of Executive Vice President, effective June 1, 2025.

    Mr. Guimaraes has over 30 years of experience in the mining industry, most recently in an executive advisory capacity and through several board directorships. His career spans a broad range of base and precious metals producers, having supported the development, expansion, and ongoing operations of copper, zinc, lead, gold, and silver mines in Canada, Chile, Peru, Mexico and Argentina. Mr. Guimaraes previously acted as the Chief Financial Officer at Sierra Metals between 2014 and 2023, and he was with Aur Resources between 1995 and 2007, ultimately serving as Executive Vice-President, Finance and Chief Financial Officer, until its acquisition by Teck Resources in 2007 for US$4.1 billion. Prior to 1995, he worked in the Toronto mining group of PricewaterhouseCoopers. Mr. Guimaraes is a Chartered Professional Accountant (CPA, CA), a graduate of the ICD-Rotman Directors Education Program (ICD.D) and holds a Bachelor of Arts in Administrative and Commercial Studies from Western University.

    Mark Brennan, Executive Chairman, commented: “On behalf of the Board and Management, I would like to welcome Ed to the team. We had very strong success working together growing Sierra Metals, and his extensive financial and operational experience supporting development and expansion of projects will add significant benefit to the Company as we continue to grow the Minera Don Nicolas gold mine to its full potential and advance the Lagoa Salgada VMS and Mont Sorcier High Purity Iron Ore Projects.”

    About Cerrado

    Cerrado Gold is a Toronto-based gold production, development, and exploration company. The Company is the 100% owner of the producing Minera Don Nicolás and Las Calandrias mine in Santa Cruz province, Argentina. In Portugal, the Company holds an 80% interest in the highly prospective Lagoa Salgada VMS project through its position in Redcorp – Empreendimentos Mineiros, Lda. In Canada, Cerrado Gold is developing its 100% owned Mont Sorcier Iron project located outside of Chibougamou, Quebec.

    In Argentina, Cerrado is maximizing asset value at its Minera Don Nicolas operation through continued operational optimization and is growing production through its operations at the Las Calandrias heap leach project. An extensive campaign of exploration is ongoing to further unlock potential resources in our highly prospective land package in the heart of the Deseado Masiff.

    In Portugal, Cerrado is focused on the exploration and development of the highly prospective Lagoa Salgada VMS project located on the prolific Iberian Pyrite Belt in Portugal. The Lagoa Salgada project is a high-grade polymetallic project, demonstrating a typical mineralization endowment of zinc, copper, lead, tin, silver, and gold. Extensive exploration upside potential lies both near deposit and at prospective step-out targets across the large 7,209-hectare property concession. Located just 80km from Lisbon and surrounded by exceptional infrastructure, Lagoa Salgada offers a low-cost entry to a significant exploration and development opportunity, already showing its mineable scale and cashflow generation potential.

    In Canada, Cerrado holds a 100% interest in the Mont Sorcier high purity Iron project, which has the potential to produce a premium iron concentrate over a long mine life at low operating costs and low capital intensity. Furthermore, its high grade and high purity product facilitates the migration of steel producers from blast furnaces to electric arc furnaces, contributing to the decarbonization of the industry and the achievement of sustainable development goals.

    For more information about Cerrado please visit our website at: www.cerradogold.com.

    Mark Brennan
    CEO and Chairman

    Mike McAllister
    Vice President, Investor Relations
    Tel: +1-647-805-5662
    mmcallister@cerradogold.com

    Disclaimer

    NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

    This press release contains statements that constitute “forward-looking information” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that discusses predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.

    Forward-looking statements contained in this press release include, without limitation, statements regarding the business and operations of Cerrado.

    SOURCE: Cerrado Gold Inc.

    View the original press release on ACCESS Newswire

  • Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

    Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

    mNEXSPIKE becomes Moderna’s third FDA-approved product

    CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention (CDC).[1]

    “The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,” said Stéphane Bancel, Chief Executive Officer of Moderna. “COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA’s timely review and thank the entire Moderna team for their hard work and continued commitment to public health.”

    The FDA’s approval of mNEXSPIKE is based on results from a randomized, observer-blind, active-controlled Phase 3 clinical trial (ClinicalTrials.gov Identifier: NCT05815498), which enrolled approximately 11,400 participants aged 12 years and older. The primary efficacy objective in this study was to demonstrate the non-inferior vaccine efficacy against COVID-19 starting 14 days after mNEXSPIKE compared to that after the comparator vaccine, mRNA-1273 (Spikevax®), Moderna’s original COVID-19 vaccine. Participants received either a 10 μg dose of mRNA-1283 or a 50 μg dose of mRNA-1273. mRNA-1283 showed a 9.3% higher relative vaccine efficacy (rVE) compared to mRNA-1273 in individuals aged 12 years and older, and in a descriptive sub-group analysis, a 13.5% higher rVE in adults aged 65 and older.

    In the Phase 3 trial, mRNA-1283 was found to have a similar safety profile to mRNA-1273, with fewer local reactions and comparable systemic reactions. The most commonly solicited side effects were injection site pain, fatigue, headache and myalgia.

    Moderna expects to have mNEXSPIKE available for eligible populations in the U.S. for the 2025-2026 respiratory virus season, alongside Spikevax and mRESVIA®, the Company’s approved respiratory syncytial virus (RSV) vaccine.

    mRNA-1283 is under review with regulators in multiple markets around the world.

    About Moderna
    Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

    Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

    mNEXSPIKE®, mRESVIA® and Spikevax®are registered trademarks of Moderna.

    INDICATION
    mNEXSPIKE is a vaccine to protect against COVID-19. mNEXSPIKE is for people who have received a COVID-19 vaccine before and are:

    • 65 years of age and older, or

    • 12 years through 64 years of age at high risk for severe COVID-19.

    Vaccination with mNEXSPIKE may not protect all people who receive the vaccine.

    IMPORTANT SAFETY INFORMATION

    You should not get mNEXSPIKE if you hada severe allergic reaction after a previous dose of either mNEXSPIKE, SPIKEVAX (COVID-19 Vaccine, mRNA), or any Moderna COVID-19 vaccine or to any ingredient in these vaccines.

    What are the risks of mNEXSPIKE?
    There is a very small chance that mNEXSPIKE could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to 1 hour after getting a dose of mNEXSPIKE. For this reason, your healthcare provider may ask you to stay for a short time at the place where you received your vaccine. Signs of a severe allergic reaction can include:

    • Trouble breathing

    • Swelling of your face and throat

    • A fast heartbeat

    • A rash all over your body

    • Dizziness and weakness

    Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received mRNA COVID-19 vaccines. Myocarditis and pericarditis following mRNA COVID-19 vaccines have occurred most commonly in males 12 years through 24 years of age. You should seek medical attention right away if you or your child has any of the following symptoms after receiving the vaccine, particularly during the 2 weeks after receiving a dose of the vaccine:

    • Chest pain

    • Shortness of breath

    • Feelings of having a fast-beating, fluttering, or pounding heart

    Side effects that have been reported in clinical trials with mNEXSPIKE include:

    • Injection site reactions: pain, tenderness and swelling of the lymph nodes in the same arm of the injection, swelling (hardness), and redness.

    • General side effects: fatigue, headache, muscle pain, joint pain, chills, nausea, vomiting, and fever

    Tell your vaccination provider about all of your medical conditions, including if you:

    • have any allergies

    • had a severe allergic reaction after receiving a previous dose of any COVID-19 vaccine

    • have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)

    • have a fever

    • have a bleeding disorder or are on a blood thinner

    • are immunocompromised or are on a medicine that affects your immune system

    • are pregnant or plan to become pregnant

    • are breastfeeding

    • have received any other COVID-19 vaccine

    • have ever fainted in association with an injection

    These may not be all the possible side effects of mNEXSPIKE. Ask your healthcare provider about any side effects that concern you. You may report side effects to Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or http://vaers.hhs.gov.

    Please click for mNEXSPIKE Full Prescribing Information.

    Forward-Looking Statements
    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the efficacy, safety and tolerability of mNEXSPIKE; and the availability of Moderna’s respiratory vaccines for the 2025-2026 season. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

    Moderna Contacts
    Media:
    Chris Ridley
    Head of Global Media Relations
    +1 617-800-3651
    Chris.Ridley@modernatx.com

    Investors:
    Lavina Talukdar
    Senior Vice President & Head of Investor Relations
    +1 617-209-5834
    Lavina.Talukdar@modernatx.com

    [1] https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html

    SOURCE: Moderna, Inc.

    View the original press release on ACCESS Newswire

  • Nexalin and FatPipe Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    Nexalin and FatPipe Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESS Newswire / May 30, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and FatPipe, Inc. (Nasdaq:FATN) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, May 31, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

    Access the interviews in their entirety at:

    In an exclusive interview, Nexalin CEO Mark White appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into the Company’s growing clinical data supporting its non-invasive, frequency-based deep brain stimulation device, as well as progress on its new Gen-3 HALO™ Clarity & Virtual Clinic model. Nexalin’s solutions have shown clinically meaningful improvements in treating conditions such as insomnia, PTSD, and traumatic brain injuries – conditions that affect millions but have limited effective treatments – positioning Nexalin as an emerging leader in a market poised for substantial growth, projected to reach $537 billion by 2030.

    In an exclusive interview, Dr. Ragula Bhaskar, CEO of FatPipe, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss how the company is transforming enterprise connectivity through its patented, software-defined networking technologies. With a product suite spanning SD-WAN, Secure Access Service Edge (SASE), and Network Monitoring Services (NMS), FatPipe enables over 2,500 customers – including government agencies, financial institutions, and healthcare providers – to unify, secure, and optimize their networks across cloud, hybrid, and on-premise environments. Dr. Bhaskar highlights FatPipe’s robust financial performance, including $17.9 million in revenue and $4.4 million in net income for fiscal 2024, and outlines the company’s growth strategy focused on global expansion, product innovation, and deepening its high-margin, subscription-based revenue model. Positioned at the intersection of three multi-billion-dollar markets and operating as a “Rule of 40” business, FatPipe offers investors a compelling blend of profitability, scalability, and exposure to the accelerating digital infrastructure megatrend.

    NXL and FATN are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.

    About Nexalin Technology, Inc.
    Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin’s products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects. The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil, and Oman. Additional information about the Company is available at: https://nexalin.com/.

    About FatPipe, Inc.

    FatPipe pioneered the concept of software-defined wide area networking (SD-WAN) and hybrid WANs that eliminate the need for hardware and software or cooperation from ISPs and allows companies and service providers to control multi-link network traffic. FatPipe currently has 12 U.S. patents related to multipath, software-defined networking. FatPipe products are sold by 200+ resellers worldwide. For more information, visit www.fatpipeinc.com. Follow us on X @FatPipe_Inc.

    To learn more, visit www.fatpipeinc.com or contact sales321@fatpipeinc.com.

    About RedChip Companies

    RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.

    To learn more about RedChip’s products and services, please visit:

    https://www.redchip.com/corporate/investor_relations

    “Discovering Tomorrow’s Blue Chips Today”™

    Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

    Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

    Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

    Follow RedChip on Twitter: https://twitter.com/RedChip

    Follow RedChip on YouTube: https://www.youtube.com/@redchip

    Follow RedChip on Rumble: https://rumble.com/c/c-3068340

    Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

    Contact:

    Dave Gentry
    RedChip Companies Inc.
    1-407-644-4256
    info@redchip.com

    SOURCE: RedChip Companies, Inc.

    View the original press release on ACCESS Newswire